Tien Dam, MD is the CMO of Brenig Therapeutics. Tien brings over two decades of extensive clinical research experience to her current role. Throughout her career, she has been pivotal in drug development, within both the biotechnology and pharmaceutical organizations.

Before leading Brenig Therapeutics, Tien was the Vice President of Clinical Development at Neumora Therapeutics. She was responsible for strategy and execution of all clinical programs across neuropsychiatry and neurodegeneration, including Major Depressive Disorder, Bipolar Disorder, Schizophrenia, Agitation Associated with Dementia due to Alzheimer’s disease, Parkinson’s disease and ALS.  

Prior to Neumora Therapeutics, Tien was the Head of Movement Disorders at Biogen, where she led disease area strategy and business development for the Therapeutic Area. She oversaw the development of multiple programs in Parkinson’s disease, atypical Parkinsonism, Essential tremor, Huntington’s disease, and ataxia. She supported multiple targets including tau, alpha-synuclein, LRRK2, GBA, ataxin-2, ataxin-3, HTT, and GABA with small molecules, monoclonal antibodies, anti-sense oligonucleotides, and gene therapy. Tien is an advisor and industry representative for non-profit organizations and patient advocacy groups. Prior to Biogen, Tien worked at Merck and supported programs in Alzheimer’s disease, insomnia, and anesthesia. 

Prior to joining the pharmaceutical industry, Tien was in academia with research, teaching, and clinical responsibilities during her tenure in the Departments of Medicine at Columbia University and University of California, San Diego. Her research interest was in aging, including frailty, sarcopenia, osteoporosis, and functional decline in home bound older adults. She was the Principal Investigator of multiple grants from the NIH and Foundations and has 60+ peer-reviewed publications.  

Tien holds a B.S. in Biomedical Sciences from University of California, Riverside, an M.D. from University of California, Los Angeles. She completed an Internal Medicine residency and Geriatrics fellowship at the University of California, San Diego.